[1] ZHANG J, MILLER A, LI Y, et al. Comparison of Multiple Chronic Obstructive Pulmonary Disease (COPD) Indices in Chinese COPD Patients. Tuberc Respir Dis (Seoul). 2018; 81(2):116-122.
[2] 滕方艳.全科护理对老年慢性阻塞性肺疾病(COPD)患者的应用效果观察[J].中西医结合心血管病电子杂志,2016,4(27):98.
[3] SYAMLAL G, DODD KE, MAZUREK JM. Asthma, chronic obstructive pulmonary disease, and asthma-COPD overlap among US working adults. J Asthma. 2023;60(4):718-726.
[4] HERATH SC, NORMANSELL R, MAISEY S, et al. Prophylactic antibiotic therapy for chronic obstructive pulmonary disease (COPD). Cochrane Database Syst Rev. 2018;10(10): CD009764.
[5] BAKER CL, ZOU KH, SU J. Risk assessment of readmissions following an initial COPD-related hospitalization. Int J Chron Obstruct Pulmon Dis. 2013;8:551-559.
[6] 余学庆,李建生,李力.慢性阻塞性肺疾病(COPD)中医证候分布规律研究[J].河南中医学院学报,2003,18(4):44-46.
[7] TORRES-SÁNCHEZ I, CABRERA-MARTOS I, DÍAZ-PELEGRINA A, et al. Physical and Functional Impairment During and After Hospitalization in Subjects With Severe COPD Exacerbation. Respir Care. 2017; 62(2):209-214.
[8] 史锁芳,曹世宏.清源化痰颗粒治疗慢性阻塞性肺疾病(COPD)发作期的临床研究[J].南京中医药大学学报,2000,16(2):81-83.
[9] SAHAKIAN E, CHEN J, POWERS JJ, et al. Essential role for histone deacetylase 11 (HDAC11) in neutrophil biology. J Leukoc Biol. 2017;102(2):475-486.
[10] 亓晓玉,肖曼,李彩霞,等.目标管理理论为框架的健康宣教对慢性阻塞性肺疾病(COPD)恢复期患者心理状态及疾病不确定感的影响[J].中国健康心理学杂志,2024, 32(9):1395-1399.
[11] Expert group on Clinical Practice of chronic obstructive pulmonary disease. Practice of clinical diagnosis and treatment of chronic obstructive pulmonary disease. Int Respir J. 2012;42(6):401-409.
[12] 刘蕾,李宇航.慢性阻塞性肺疾病(COPD)相关生物学标志物研究进展[J].中华中医药学刊,2010,28(9):1857-1861.
[13] HUO B, MANOS D, XU Z, et al. Screening Criteria Evaluation for Expansion in Pulmonary Neoplasias (SCREEN). Semin Thorac Cardiovasc Surg. 2023;35(4):769-780.
[14] MARÇÔA R, RODRIGUES DM, DIAS M, et al. Classification of Chronic Obstructive Pulmonary Disease (COPD) according to the new Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2017: Comparison with GOLD 2011. COPD. 2018;15(1):21-26.
[15] 郁东伟,束永前.中医综合疗法治疗慢性阻塞性肺疾病(COPD)稳定期营养状况及肺功能的改善评价[J].中华中医药学刊,2015, 33(11):2608-2610.
[16] DRANSFIELD MT, KUNISAKI KM, STRAND MJ, et al. Acute Exacerbations and Lung Function Loss in Smokers with and without Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med. 2017;195(3):324-330.
[17] BLASI F, NERI L, CENTANNI S, et al. Clinical Characterization and Treatment Patterns for the Frequent Exacerbator Phenotype in Chronic Obstructive Pulmonary Disease with Severe or Very Severe Airflow Limitation. COPD. 2017;14(1):15-22.
[18] 桂燕华.慢性阻塞性肺疾病(COPD)并发呼吸衰竭行无创机械通气护理体会[J].当代医学, 2009,15(28):106-107.
[19] D’ANNA SE, ASNAGHI R, CARAMORI G, et al. High-resolution computed tomography quantitation of emphysema is correlated with selected lung function values in stable COPD. Respiration. 2012;83(5):383-390.
[20] DE-TORRES JP, O’DONNELL DE, MARÍN JM, et al. Clinical and Prognostic Impact of Low Diffusing Capacity for Carbon Monoxide Values in Patients With Global Initiative for Obstructive Lung Disease I COPD. Chest. 2021; 160(3):872-878.
[21] 刘畅.综合康复护理措施对老年慢性阻塞性肺疾病(COPD)患者肺功能的影响[J].临床医药文献电子杂志,2016,3(17):3414-3415.
[22] VAN DER LEEST S, DUIVERMAN ML. High-intensity non-invasive ventilation in stable hypercapnic COPD: Evidence of efficacy and practical advice. Respirology. 2019;24(4): 318-328.
[23] 石峰.老年慢性阻塞性肺疾病(COPD)患者呼吸衰竭合并肺部感染及死亡的相关因素[J].浙江临床医学,2002,4(12):897-898.
[24] MATKOVIC Z, HUERTA A, SOLER N, et al. Predictors of adverse outcome in patients hospitalised for exacerbation of chronic obstructive pulmonary disease. Respiration. 2012;84(1):17-26.
[25] BRÄUNLICH J, TURBA K, WIRTZ H. Reversibility of Hypercapnia after an Acute Exacerbation of COPD. Respiration. 2022; 101(9):816-822.
[26] 陈孝谦.血清降钙素原与Anthonisen分型指导慢性阻塞性肺疾病(COPD)急性加重期抗菌药物应用的对比研究[D].合肥:安徽医科大学,2013.
|